32 min listen
Hem-Onc News: Aspirin linked to cancer progression in older adults, inhibitor could 'alter landscape' of RET+ tumors, and Black-White gap closing
FromBlood & Cancer
Hem-Onc News: Aspirin linked to cancer progression in older adults, inhibitor could 'alter landscape' of RET+ tumors, and Black-White gap closing
FromBlood & Cancer
ratings:
Length:
15 minutes
Released:
Sep 1, 2020
Format:
Podcast episode
Description
MDedge Hematology-Oncology news for the first week of September 2020. Aspirin may accelerate cancer progression in older adults: https://bit.ly/2ENHRUc ASPREE trial: https://bit.ly/2QAsMYW Meta-analysis: https://bit.ly/2D6rXnl AsCaP: https://bit.ly/2G06X2I Black/White gap gone: ‘The only cancer where this has happened’: https://bit.ly/3jm8PBm Source: https://bit.ly/3lv4u0m Selpercatinib 'poised to alter the landscape' of RET+ cancers: https://bit.ly/34PYSbs Lung cancer results: https://bit.ly/3gB1FY7 Thyroid cancer results: https://bit.ly/2EHhCz5 Study confirms it's possible to get COVID-19 twice: https://bit.ly/3bd4wWg Email the show: podcasts@mdedge.com Learn more about MDedge and Blood & Cancer: https://www.mdedge.com/podcasts
Released:
Sep 1, 2020
Format:
Podcast episode
Titles in the series (100)
Is this a good study? The statistics tell the story: Ever read through a study and wondered how to apply the hazard ratio, or if you should change your practice because of a secondary endpoint finding? In this episode, , of the University of Pennsylvania, Philadelphia, explains all the common terms and... by Blood & Cancer